Mama-Match
SkinnyRx review
$199/mo semaglutide, $299/mo tirzepatide, with a sublingual tablet option — and an FDA warning letter to its parent, Lean Rx, Inc., dated 02/20/2026 that its own site never mentions.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Referral link, separate from the score
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
SkinnyRx at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed on the public site we reviewed
- Brand-name
- Compounded only
How we scored SkinnyRx
Each factor is judged from SkinnyRx's actual pricing, disclosures and support, then combined into the Mama-Match Score of 48/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The start feels transactional — more cash register than welcome.
The cost is unpredictable, hidden behind a quiz, or in the premium range.
Little public detail about who oversees your care, and how.
Coverage is limited or gated behind a signup.
Support is thin once the prescription ships.
Canceling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Medium
- Primary source
- skinnyrx.com
$199 for the injectable, $249 for the sublingual tablets and $299 for tirzepatide in either form — pulled from the site's own structured data, because the page returns only an empty shell. No state list anywhere on the public site.
What to expect when you sign up
We walked SkinnyRx's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1Structured product data lists one flat price per form (injectable or tablet) for each molecule
- 2Complete an online quiz-based intake
- 3A licensed provider reviews and prescribes if appropriate
- 4Medication ships if approved
What we noticed
- Offers a real choice most of the providers reviewed here doesn't: sublingual tablets alongside the injectable, for both molecules
- Its own code carries an internal flag literally named "no_membership" next to its pricing data
- The price is not in the page as served; it appears only after the site's scripts finish loading
- No state list published anywhere we could find
- The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not SkinnyRx's own copy
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Injectable |
| Oral semaglutide | $249 | Sublingual tablets |
| Compounded tirzepatide | $299 | Injectable |
| Oral tirzepatide | $299 | Sublingual tablets |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what SkinnyRx disclosed publicly at our last review and change often; confirm the current number on SkinnyRx's site.
What we like
- Offers sublingual tablets as a genuine alternative to injections for both molecules
- Flat pricing regardless of dose
- Internal site code carries a "no_membership" flag consistent with no separate fee
The caveats
- No state list published anywhere on the public site
- Pricing only surfaces in compiled app data, not a plain page read
- Nothing maternal-specific — general telehealth framing
- The FDA issued its parent company, Lean Rx, Inc., an FDA warning letter dated 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing claims implying its compounded products share FDA-approved status with brand-name drugs like Mounjaro and Zepbound, which they don't — confirmed on FDA.gov, and never mentioned anywhere on SkinnyRx's own site
SkinnyRx for moms: our verdict
$199/mo semaglutide, $299/mo tirzepatide, with a sublingual tablet option — and an FDA warning letter to its parent, Lean Rx, Inc., dated 02/20/2026 that its own site never mentions. It runs about $199/mo, flat across every dose.
We looked at SkinnyRx the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What SkinnyRx actually costs
- Compounded semaglutide — Injectable: $199/mo
- Oral semaglutide — Sublingual tablets: $249/mo
- Compounded tirzepatide — Injectable: $299/mo
- Oral tirzepatide — Sublingual tablets: $299/mo
That's roughly in line with our list's median of ~$175/mo.
SkinnyRx prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.
The medications SkinnyRx prescribes
SkinnyRx prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. These are compounded formulas from a licensed pharmacy — the reason the price stays low — but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
There's a needle-free oral or sublingual option on the menu, which appeals to moms who have been putting off injections — just set your expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions used in the trials.
Where it operates. SkinnyRx publishes no state list, so confirm it serves yours before you pay anything.
Where SkinnyRx fits — and where it doesn't — for moms
A good fit if…
- you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
A standing caution for moms: GLP-1 medications are not proven safe during pregnancy or breastfeeding, and every label advises against use. None of this changes that — plan the timing with your own healthcare provider.
The bottom line
SkinnyRx is a provider we list only with the full story attached — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: Moms willing to verify SkinnyRx's compounding and ingredient claims for themselves rather than take its labels or marketing at face value — the FDA found the site misrepresents who actually compounds these products and implies an FDA-approved status they don't have. Read the FDA's letter before you weigh in the tablet option or the flat pricing.
Other gentle first steps
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
$99/mo semaglutide, $149/mo tirzepatide, one flat price with both medications in a single account — and an intake that walks you through it instead of cornering you with a quiz.
- Meet Enhance MD
$249/mo semaglutide, $329/mo tirzepatide with no commitment ($212 and $280 on the 12-month plan), a named Medical Director and a real video visit before anything is prescribed.
- Meet Gala Health
$179/mo for either medication, flat across doses, with a genuinely gentle microdose tier — if you can live with an annual plan and a pharmacy it will not name.
Keep comparing SkinnyRx
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
SkinnyRx, answered
- Does SkinnyRx offer a non-injection option?
- Yes — sublingual tablets are available for both semaglutide ($249/mo) and tirzepatide ($299/mo), alongside the injectable forms ($199/mo and $299/mo).
- Does SkinnyRx charge a separate membership fee?
- Its own site code carries an internal flag named "no_membership" alongside its pricing data, consistent with a flat medication price with nothing stacked on top — though this wasn't confirmed through a live checkout.
- Does SkinnyRx have an FDA warning letter?
- Yes — the FDA issued one dated 02/20/2026 (ref. 717989) to Lean Rx, Inc., SkinnyRx's legal entity, after reviewing skinnyrx.com in December 2025. It found the site's product labels falsely display "SkinnyRx" as the compounder of its semaglutide and tirzepatide products, and that marketing lines like "from the same family as GLP-1 treatments like Mounjaro and Zepbound" wrongly imply FDA-approved status for products that don't have it. We confirmed this directly on FDA.gov; SkinnyRx's own site makes no mention of it.
Prices, states and verification reflect what SkinnyRx disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.